Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cassano

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
British Journal of Cancer|December 14, 2006
Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trialC Barone, M Landriscina, M Quirino, et al.
Oncology|December 21, 2006
Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracilM Ciaparrone, M Quirino, G Schinzari, et al.
The Cochrane Database of Systematic Reviews|August 12, 2025
Vitamin D supplementation in pregnant or breastfeeding women or young children for preventing asthmaBonnie K Patchen, Cora M Best, Jocelyn Boiteau, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
High-dose folinic acid (HDFA) combined with 5-fluorouracil (5-FU) in first line chemotherapy of advanced large bowel cancerC Barone, A Astone, C Garufi, et al.
Journal of Cancer|January 2, 2015
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro VeritasA Orlandi, M Di Salvatore, C Bagalà, et al.
The Cochrane Database of Systematic Reviews|October 18, 2021
Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adultsSajin Bae, Elena Kamynina, Heather M Guetterman, et al.
Free Radical Biology & Medicine|May 22, 2013
Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung functionWenbo Tang, Amy R Bentley, Stephen B Kritchevsky, et al.
Free Radical Biology & Medicine|March 6, 2012
Genetic variation in antioxidant enzymes and lung functionAmy R Bentley, Stephen B Kritchevsky, Tamara B Harris, et al.
Anticancer Research|May 30, 2008
A histochemical approach to the evaluation of the in vivo cytotoxicity of the nitrobutadienes (1E,3E)-1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene and methyl (2Z,4E)-2-methylsulfanyl-5-(1-naphthyl)-4-nitro-2,4-pentadienoate in mice liver and kidneyC Fenoglio, A Grosso, G Petrillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2016
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worseA Orlandi, M A Calegari, M Martini, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|December 14, 2006
Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trialC Barone, M Landriscina, M Quirino, et al.
Oncology|December 21, 2006
Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracilM Ciaparrone, M Quirino, G Schinzari, et al.
The Cochrane Database of Systematic Reviews|August 12, 2025
Vitamin D supplementation in pregnant or breastfeeding women or young children for preventing asthmaBonnie K Patchen, Cora M Best, Jocelyn Boiteau, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
High-dose folinic acid (HDFA) combined with 5-fluorouracil (5-FU) in first line chemotherapy of advanced large bowel cancerC Barone, A Astone, C Garufi, et al.
Journal of Cancer|January 2, 2015
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro VeritasA Orlandi, M Di Salvatore, C Bagalà, et al.
The Cochrane Database of Systematic Reviews|October 18, 2021
Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adultsSajin Bae, Elena Kamynina, Heather M Guetterman, et al.
Free Radical Biology & Medicine|May 22, 2013
Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung functionWenbo Tang, Amy R Bentley, Stephen B Kritchevsky, et al.
Free Radical Biology & Medicine|March 6, 2012
Genetic variation in antioxidant enzymes and lung functionAmy R Bentley, Stephen B Kritchevsky, Tamara B Harris, et al.
Anticancer Research|May 30, 2008
A histochemical approach to the evaluation of the in vivo cytotoxicity of the nitrobutadienes (1E,3E)-1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene and methyl (2Z,4E)-2-methylsulfanyl-5-(1-naphthyl)-4-nitro-2,4-pentadienoate in mice liver and kidneyC Fenoglio, A Grosso, G Petrillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2016
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worseA Orlandi, M A Calegari, M Martini, et al.
Pageof 16